Select Page

The Infinium Global Research analyzes the Human Vaccines Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global human vaccines market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of human vaccines. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the human vaccines market during the period.

“We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.”

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

High Occurrences of Various Viral and Bacterial Diseases are Driving the Growth of the Global Human Vaccines Market

The high occurrences of various viral and bacterial diseases are driving the growth of the global human vaccines market. The intervention of governments as well as other non-governmental agencies through various awareness campaigns is aiding the increasing awareness about the benefits of human vaccines among the public worldwide. The increase in awareness is expected to enhance the growth of the human vaccines market, as it prompts more people to seek vaccinations. The compulsory and non-compulsory vaccination as part of immunization programmers for children against certain diseases are expected to drive the growth of the global human vaccines market, as these vaccines are essential to prevent some of the eradicated diseases from re-emerging. Minimal or low occurrence of fatal or serious side effects related to human vaccines as per the Among the age group, pediatric segment accounts for more than 50% of the overall human vaccines demand.

Among the vaccine products, the pneumococcal segment accounts for significant market share. Combination of human vaccines are expected to attain considerable growth during the forecast period. As there are minimal or relatively low risk of serious or fatal side effects related to the human vaccines people are now more open to the use of vaccines. Moreover, the assurance from major health organizations such as WHO and AMA, drives the adoption of human vaccines significantly and it is expected to drive the growth of the global human vaccines market during the forecast period.

Stringent regulations set by various countries and high costs associated with research and development, manufacturing, handling, storage and transportation are the major challenges for the major players in the global human vaccines market. The technical expertise and patents by a few players in the market are among the challenges for the new entrants in this market; moreover, it requires a huge investment for new players to enter the market. These are expected to remain as the major restraints for the global human vaccines market during the forecast period. Due to the intense competition, mergers and acquisitions are expected to be a pathway for major players for consolidation in the global human vaccines market during the forecast period. Opportunities are expected to be there for the major players to expand in the developing and poor economies as governments focus on immunization programmers against various diseases during the forecast period.

Enquire Here Get Customization & Check Discount for Report @  

Human Vaccines Market: Segmentation

The report segments the global human vaccines market by product, disease condition and region. On the basis of product, the market is segmented as live attenuated vaccines, killed vaccines, conjugate vaccines, and synthetic vaccines. Based on disease conditions, the market is segmented as pneumonia, influenza, hepatitis, HPV and others.

North America Leads the Global Human Vaccines Market

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and the Rest of the World. North America leads the global human vaccines market due to the increasing number of patients with cancers. Furthermore, infectious diseases are increasing considerably in countries such as Canada and USA. Huge investments from governments for vaccine research and immunization programmers drive the North American human vaccines market. The presence of major pharmaceutical companies’ research & development and production facilities of human vaccines drive the European region as the second-largest human vaccine market. A significant portion of the human vaccines manufactured in Europe are exported to other regions.

However, the vaccination programmers conducted by various healthcare services in European countries drive the demand for human vaccines in the European region. The presence of large population in countries such as China and India drive the growth of the Asia-Pacific human vaccines market. Asia-Pacific region is expected to emerge as the fastest-growing market due to government support and investment in the immunization programmers in various countries. Latin American region is expected to experience a surge in demand for human vaccines for cancer and various infectious diseases. African region relies heavily on UNICEF for human vaccines as they are heavily subsidized. African market present opportunity for expansion for major human vaccines manufacturers, as there is scope for immunization programmers for various diseases. Increasing demand for polio, pertussis and influenza vaccines is expected to drive the growth of the Middle East human vaccines market during the forecast period.

Human Vaccines Market: Competitive Landscape

  • CSL Limited,
  • GlaxoSmithKline PLC,
  • Merck & Co. Inc.,
  • Novartis AG,
  • Pfizer Inc.,
  • Takeda Pharmaceutical Company Limited.,
  • Emergent BioSolutions Inc.,
  • Bavarian Nordic,
  • Sanofi Pasteur
  • Serum Institute of India Pvt Ltd.

Browse Detailed TOC, Description, and Companies Mentioned in Report @

About Us

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide the knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.